Comparison of Plasmodium berghei challenge models for the evaluation of pre-erythrocytic malaria vaccines and their effect on perceived vaccine efficacy

Malaria Journal

Volumn 9, Issue 1, 2010, Pages

  Leitner, Wolfgang W ^a,b   Bergmann Leitner, Elke S ^a   Angov, Evelina ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CIRCUMSPOROZOITE PROTEIN; DNA VACCINE; MALARIA VACCINE; CIRCUMSPOROZOITE PROTEIN, PROTOZOAN; PROTOZOAL PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANOPHELES STEPHENSI; ARTICLE; BLOOD SMEAR; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; GENE GUN IMMUNIZATION; GENETIC VARIABILITY; HINDLIMB; IMMUNE RESPONSE; INOCULATION; MALE; MOSQUITO; MOUSE; NONHUMAN; PLASMODIUM BERGHEI; PLASMODIUM BERGHEI INFECTION; PLASMODIUM YOELII; RELIABILITY; REPRODUCIBILITY; SKIN; SPOROZOITE; TITRIMETRY; VIRUS VIRULENCE; ANIMAL; ANOPHELES; BAGG ALBINO MOUSE; BIOLISTIC TRANSFORMATION; COMPARATIVE STUDY; DISEASE CARRIER; DISEASE MODEL; GENETICS; IMMUNOLOGY; INSECT BITE; INTRADERMAL DRUG ADMINISTRATION; INTRAMUSCULAR DRUG ADMINISTRATION; MALARIA; PARASITOLOGY; PATHOGENICITY; PLASMID; VACCINATION;

ANIMALS; ANOPHELES; BIOLISTICS; DISEASE MODELS, ANIMAL; FEMALE; INJECTIONS, INTRADERMAL; INJECTIONS, INTRAMUSCULAR; INSECT BITES AND STINGS; INSECT VECTORS; MALARIA; MALARIA VACCINES; MICE; MICE, INBRED BALB C; PLASMIDS; PLASMODIUM BERGHEI; PROTOZOAN PROTEINS; REPRODUCIBILITY OF RESULTS; SKIN; SPOROZOITES; VACCINATION; VACCINES, DNA;

EID: 77952694574     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-9-145     Document Type: Article

References (46)

1. The hope but challenge for developing a vaccine that might control malaria. MF Good, Eur J Immunol 2009 39 939 943 10.1002/eji.200939390 19350585
2. Efficacy of murine malaria sporozoite vaccines: implications for human vaccine development. JE Egan JL Weber WR Ballou MR Hollingdale WR Majarian DM Gordon WL Maloy SL Hoffman RA Wirtz I Schneider GR Woollett JF Young WT Hockmeyer, Science 1987 236 453 456 10.1126/science.3551073 3551073
3. Major animal models in malarial research: rodent. FEG Cox, Malaria: Principles and Practice of Malariology Edinburgh: Churchill Livingstone, IA M, 1988 2 1503 1544
4. Studies on sporozoite-induced infections of rodent malaria. 3. The course of sporozoite-induced Plasmodium berghei in different hosts. R Nussenzweig R Herman J Vanderberg M Yoeli H Most, Am J Trop Med Hyg 1966 15 684 689 5917626
5. Differences in susceptibility among mouse strains to infection with Plasmodium berghei (ANKA clone) sporozoites and its relationship to protection by gamma-irradiated sporozoites. RI Jaffe GH Lowell DM Gordon, Am J Trop Med Hyg 1990 42 309 313 2184689
6. Susceptibility of different strains of mice to hepatic infection with Plasmodium berghei. LF Scheller RA Wirtz AF Azad, Infect Immun 1994 62 4844 4847 7927764
7. Studies on the infectivity of Plasmodium berghei sporozoites in experimental hosts. M Coosemans M Wery E Van Marck G Timperman, Ann Soc Belg Med Trop 1981 61 349 368 7032427
8. In vivo induction of the nitric oxide pathway in hepatocytes after injection with irradiated malaria sporozoites, malaria blood parasites or adjuvants. AK Nussler L Renia V Pasquetto F Miltgen H Matile D Mazier, Eur J Immunol 1993 23 882 887 10.1002/eji.1830230417 8458376
9. Plasmodium berghei: quantitation of sporozoites injected by mosquitoes feeding on a rodent host. JP Vanderberg, Exp Parasitol 1977 42 169 181 10.1016/0014-4894(77)90075-3 324786
10. Quantitation of Plasmodium falciparum sporozoites transmitted in vitro by experimentally infected Anopheles gambiae and Anopheles stephensi. JC Beier JR Davis JA Vaughan BH Noden MS Beier, Am J Trop Med Hyg 1991 44 564 570 2063960
11. Quantitative imaging of Plasmodium transmission from mosquito to mammal. R Amino S Thiberge B Martin S Celli S Shorte F Frischknecht R Menard, Nat Med 2006 12 220 224 10.1038/nm1350 16429144 (Pubitemid 43214749)
12. Delayed migration of Plasmodium sporozoites from the mosquito bite site to the blood. S Sidjanski JP Vanderberg, Am J Trop Med Hyg 1997 57 426 429 9347958
13. Intravital microscopy demonstrating antibody-mediated immobilisation of Plasmodium berghei sporozoites injected into skin by mosquitoes. JP Vanderberg U Frevert, Int J Parasitol 2004 34 991 996 10.1016/j.ijpara.2004.05.005 15313126
14. Genetically attenuated Plasmodium berghei liver stages persist and elicit sterile protection primarily via CD8 T cells. AK Mueller M Deckert K Heiss K Goetz K Matuschewski D Schluter, Am J Pathol 2007 171 107 115 10.2353/ajpath.2007.060792 17591958
15. Assessment of antibody protection against malaria sporozoites must be done by mosquito injection of sporozoites. J Vanderberg AK Mueller K Heiss K Goetz K Matuschewski M Deckert D Schluter, Am J Pathol 2007 171 1405 1406 10.2353/ajpath.2007.070661 17823294
16. Infectivity of Plasmodium berghei sporozoites delivered by intravenous inoculation versus mosquito bite: implications for sporozoite vaccine trials. JA Vaughan LF Scheller RA Wirtz AF Azad, Infect Immun 1999 67 4285 4289 10417207
17. Plasmodium yoelii-Infected A. stephensi inefficiently transmit malaria compared to intravenous route. S Conteh R Chattopadhyay C Anderson SL Hoffman, PLoS One 2010 5 8947 10.1371/journal.pone.0008947 20126610
18. Immunization with radiation-attenuated Plasmodium berghei sporozoites induces liver cCD8alpha+DC that activate CD8+T cells against liver-stage malaria. O Jobe G Donofrio G Sun D Liepinsh R Schwenk U Krzych, PLoS One 2009 4 5075 10.1371/journal.pone.0005075 19347042
19. Polymeric linear Peptide chimeric vaccine-induced antimalaria immunity is associated with enhanced in vitro antigen loading. LM Silva-Flannery M Cabrera-Mora M Dickherber A Moreno, Infect Immun 2009 77 1798 1806 10.1128/IAI.00470-08 19237530
20. Intranasal administration of the synthetic polypeptide from the C-terminus of the circumsporozoite protein of Plasmodium berghei with the modified heat-labile toxin of Escherichia coli (LTK63) induces a complete protection against malaria challenge. JF Romero A Ciabattini P Guillaume G Frank P Ruggiero E Pettini G Del Giudice D Medaglini G Corradin, Vaccine 2009 27 1266 1271 10.1016/j.vaccine.2008.12.010 19111883
21. Life cycle and patterns of development of Plasmodium berghei in normal and experimental hosts. M Yoeli RS Upmanis J Vanderberg H Most, Mil Med 1966 131 Suppl 900 914 4380325
22. Safety, immunogenicity, and efficacy of a recombinantly produced Plasmodium falciparum circumsporozoite protein-hepatitis B surface antigen subunit vaccine. DM Gordon TW McGovern U Krzych JC Cohen I Schneider R LaChance DG Heppner G Yuan M Hollingdale M Slaoui SP Hauser P Voet JC Sadoff WR Ballou, J Infect Dis 1995 171 1576 1585 7769295
23. Human studies with synthetic peptide sporozoite vaccine (NANP)3-TT and immunization with irradiated sporozoites. DA Herrington DF Clyde JR Davis S Baqar JR Murphy JF Cortese RS Bank E Nardin D DiJohn RS Nussenzweig V Nussenzweig JR Torres J Murillo M Cortesia D Struchler MR Hollingdale M Levine, Bull World Health Organ 1990 68 Suppl 33 37 2094588
24. Safety, immunogenicity, and efficacy of a malaria sporozoite vaccine administered with monophosphoryl lipid A, cell wall skeleton of mycobacteria, and squalane as adjuvant. SL Hoffman R Edelman JP Bryan I Schneider J Davis M Sedegah D Gordon P Church M Gross C Silverman M Hollingdale D Clyde M Sztein G Losonsky S Paparello TR Jone, Am J Trop Med Hyg 1994 5 603 612
25. A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS, S Malaria Vaccine Evaluation Group. JA Stoute M Slaoui DG Heppner P Momin KE Kester P Desmons BT Wellde N Garcon U Krzych M Marchand, N Engl J Med 1997 336 86 91 10.1056/ NEJM199701093360202 8988885
26. Report of a Consultation on the Optimization of Clinical Challenge Trials for Evaluation of Candidate Blood Stage Malaria Vaccines, 18-19 March 2009, Bethesda, MD, USA. VS Moorthy C Diggs S Ferro MF Good S Herrera AV Hill EB Imoukhuede S Kumar C Loucq K Marsh CF Ockenhouse TL Richie RW Sauerwein, Vaccine 2009 27 5719 5725 10.1016/j.vaccine.2009.07.049 19654061
27. Detection of malaria liver-stages in mice infected through the bite of a single Anopheles mosquito using a highly sensitive real-time PCR. O Bruna-Romero JC Hafalla G Gonzalez-Aseguinolaza G Sano M Tsuji F Zavala, Int J Parasitol 2001 31 1499 1502 10.1016/S0020-7519(01)00265-X 11595237
28. Induction of nitric oxide synthase protects against malaria in mice exposed to irradiated Plasmodium berghei infected mosquitoes: involvement of interferon gamma and CD8+ T cells. MC Seguin FW Klotz I Schneider JP Weir M Goodbary M Slayter JJ Raney JU Aniagolu SJ Green, J Exp Med 1994 180 353 358 10.1084/jem.180.1.353 7516412
29. Immune responses induced by intramuscular or gene gun injection of protective deoxyribonucleic acid vaccines that express the circumsporozoite protein from Plasmodium berghei malaria parasites. WW Leitner MC Seguin WR Ballou JP Seitz AM Schultz MJ Sheehy JA Lyon, J Immunol 1997 159 6112 6119 9550412
30. Genetic vaccination against malaria infection by intradermal and epidermal injections of a plasmid containing the gene encoding the Plasmodium berghei circumsporozoite protein. R Weiss WW Leitner S Scheiblhofer D Chen A Bernhaupt S Mostbock J Thalhamer JA Lyon, Infect Immun 2000 68 5914 5919 10.1128/IAI.68.10.5914-5919.2000 10992502
31. C3d binding to the circumsporozoite protein carboxy-terminus deviates immunity against malaria. ES Bergmann-Leitner S Scheiblhofer R Weiss EH Duncan WW Leitner D Chen E Angov F Khan JL Williams DB Winter J Thalhamer JA Lyon GC Tsokos, Int Immunol 2005 17 245 255 10.1093/intimm/dxh205 15710912
32. C3d-defined complement receptor-binding peptide p28 conjugated to circumsporozoite protein provides protection against Plasmodium berghei. ES Bergmann-Leitner EH Duncan WW Leitner A Neutzner T Savranskaya E Angov GC Tsokos, Vaccine 2007 25 7732 7736 10.1016/j.vaccine.2007.08.030 17931754
33. Molecular adjuvants for malaria DNA vaccines based on the modulation of host-cell apoptosis. ES Bergmann-Leitner WW Leitner EH Duncan T Savranskaya E Angov, Vaccine 2009 27 5700 5708 10.1016/j.vaccine.2009.06.059 19576940
34. Removal of the circumsporozoite protein (CSP) glycosylphosphatidylinositol signal sequence from a CSP DNA vaccine enhances induction of CSP-specific Th2 type immune responses and improvesprotection against malaria infection. S Scheiblhofer D Chen R Weiss F Khan S Mostbock K Fegeding WW Leitner J Thalhamer JA Lyon, Eur J Immunol 2001 31 692 698 10.1002/1521-4141(200103)31:3<692::AID-IMMU692>3.0.CO;2-Y 11241272
35. IL-12 and NK cells are required for antigen-specific adaptive immunity against malaria initiated by CD8+ T cells in the Plasmodium yoelii model. DL Doolan SL Hoffman, J Immunol 1999 163 884 892 10395683
36. Host defenses in murine malaria: nonspecific resistance to Plasmodium berghei generated in response to Mycobacterium bovis infection or Corynebacterium parvum stimulation. JR Murphy, Infect Immun 1981 33 199 211 7021424
37. Mast cell-mediated immune responses through IgE antibody and Toll-like receptor 4 by malarial peroxiredoxin. T Furuta S Imajo-Ohmi H Fukuda S Kano K Miyake N Watanabe, Eur J Immunol 2008 38 1341 1350 10.1002/eji.200738059 18398934
38. Plasmodium falciparum infection causes proinflammatory priming of human TLR responses. MB McCall MG Netea CC Hermsen T Jansen L Jacobs D Golenbock AJ van der Ven RW Sauerwein, J Immunol 2007 179 162 171 17579034
39. TLR-mediated cell signaling by malaria GPIs. DC Gowda, Trends Parasitol 2007 23 596 604 10.1016/j.pt.2007.09.003 17980663
40. Inhibitory role of toll-like receptors agonists in Plasmodium yoelii liver stage development. J Chen W Xu T Zhou Y Ding J Duan F Huang, Parasite Immunol 2009 31 466 473 10.1111/j.1365-3024.2009.01126.x 19646211
41. Interleukin-12- and gamma interferon-dependent protection against malaria conferred by CpG oligodeoxynucleotide in mice. RA Gramzinski DL Doolan M Sedegah HL Davis AM Krieg SL Hoffman, Infect Immun 2001 69 1643 1649 10.1128/IAI.69.3.1643-1649.2001 11179339
42. Non specific resistance against malaria pre-erythrocytic stages: involvement of acute phase proteins. S Pied MD Tabone G Chatellier M Marussig C Jardel F Nosten D Mazier, Parasite 1995 2 263 268 8520801
43. Responses of female Aedes aegypti to host odours and convection currents using an olfectometer bioassay. AE Eiras PC Jepson, Bull Entomol Res 1994 84207 84211
44. Blood, sex and the mosquito: the mechanisms that control mosquito blood-feeding behavior. MJ Klowden, BioScience 1995 45 326 331 10.2307/1312493
45. Mosquitoes. RF Harwood MT James, Entomology in human and animal health New York: Macmillan Publishing Co. Inc 7 1979 169 233
46. A simple method of estimating fifty percent endpoints. LJ Reed H Muench, Am J Hyg 1938 27 493 497